1. Homepage
  2. Equities
  3. China
  4. Shanghai Stock Exchange
  5. APT Medical Inc.
  6. Summary
    688617   CNE100004C45

APT MEDICAL INC.

(688617)
  Report
End-of-day quote Shanghai Stock Exchange  -  2022-08-15
181.66 CNY   -2.39%
06/15APT Medical Inc. announces an Equity Buyback for CNY 100 million worth of its shares.
CI
06/13APT MEDICAL INC.(SHSE : 688617) added to Shanghai Stock Exchange Health Care Sector Index
CI
06/13APT Medical Inc. authorizes a Buyback Plan.
CI
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Shanghai Stock Exchange
08/10/2022 08/11/2022 08/12/2022 08/15/2022 08/16/2022 Date
187.6 194.89 193.77 186.1 181.66 Last
147465 291780 149808 356700 255021 Volume
+0.05% +3.89% -0.57% -3.96% -2.39% Change
Estimated financial data (e)
Sales 2022 1 151 M 170 M 170 M
Net income 2022 301 M 44,4 M 44,4 M
Net Debt 2022 - - -
P/E ratio 2022 40,2x
Yield 2022 0,65%
Sales 2023 1 638 M 241 M 241 M
Net income 2023 450 M 66,3 M 66,3 M
Net Debt 2023 - - -
P/E ratio 2023 26,9x
Yield 2023 0,98%
Capitalization 12 111 M 1 784 M 1 784 M
Capi. / Sales 2022 10,5x
Capi. / Sales 2023 7,39x
Nbr of Employees 1 511
Free-Float 42,0%
More Financials
Company
APT Medical Inc is a China-based company mainly engaged in the research and development, manufacture and sales of electrophysiological and vascular interventional medical devices. The Company's electrophysiological products include electrophysiological electrode catheters, controllable radiofrequency ablation electrode catheters and multichannel electrophysiological systems. Its coronary artery access products... 
More about the company
Ratings of APT Medical Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
-
More Ratings
All news about APT MEDICAL INC.
06/15APT Medical Inc. announces an Equity Buyback for CNY 100 million worth of its shares.
CI
06/13APT MEDICAL INC.(SHSE : 688617) added to Shanghai Stock Exchange Health Care Sector Index
CI
06/13APT Medical Inc. authorizes a Buyback Plan.
CI
04/28APT Medical Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
02/24APT Medical Inc. Reports Earnings Results for the Full Year Ended December 31, 2021
CI
01/12APT MEDICAL INC.(SHSE : 688617) added to Shanghai Stock Exchange Composite Index
CI
01/12APT MEDICAL INC.(SHSE : 688617) added to Shanghai Stock Exchange A Share Index
CI
01/07Certain A Shares of APT Medical Inc. are subject to a Lock-Up Agreement Ending on 7-JA..
CI
2021APT Medical Inc. Reports Earnings Results for the Nine Months Ended September 30, 2021
CI
2021Apt Medical Inc. Reports Earnings Results for the Half Year Ended June 30, 2021
CI
2021Apt Medical Inc. Announces Earnings Results for the First Quarter Ended March 31, 2021
CI
2021APT MEDICAL : Soars 245% in Shanghai Trading Debut
MT
2021Shenzhen Huitai Medical Devices Co., Ltd. Reports Earnings Results for the Full Year En..
CI
2020APT Medical Inc. has completed an IPO in the amount of CNY 1.241248 billion.
CI
2020APT Medical Inc. has filed an IPO.
CI
More news
News in other languages on APT MEDICAL INC.
06/15APT MEDICAL INC. (SHSE : 688617) annonce un rachat d'actions pour une valeur de 100 millio..
06/13APT Medical Inc. autorise un plan de rachat.
04/28APT Medical Inc. annonce ses résultats pour le premier trimestre clos le 31 mars 2022
02/24APT Medical Inc. annonce ses résultats pour l'année complète se terminant le 31 décembr..
More news
Chart APT MEDICAL INC.
Duration : Period :
APT Medical Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends APT MEDICAL INC.
Short TermMid-TermLong Term
TrendsBearishBullishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 3
Last Close Price 181,66 CNY
Average target price 260,25 CNY
Spread / Average Target 43,3%
EPS Revisions
Managers and Directors
Zheng Hui Cheng Chairman, President & General Manager
Zhen Hua Dai CFO, Board Secretary, Director & Deputy GM
Lei Gong Chairman-Supervisory Board
Yu Chen Qiu Deputy GM, Director-Product Research & Development
Li Jun Xia Independent Director
Sector and Competitors
1st jan.Capi. (M$)
APT MEDICAL INC.-35.12%1 832
SHOCKWAVE MEDICAL, INC.66.44%10 664
NOVOCURE LIMITED12.31%8 832
MASIMO CORPORATION-45.43%8 393
PENUMBRA, INC.-39.20%6 619
GETINGE AB-43.20%5 925